Internal Medicine · Traverse City, MI
NPI
1154476828
Since 2007
Specialty
Internal Medicine
Code 207R00000X
Group practices
2
Medicare group memberships
Hospitals
5
Hospital affiliations
4100 Park Forest Dr, Suite 208
Traverse City, MI, 49684
Phone (231) 935-5710
Groups this clinician bills Medicare through
Medicare paid, 2024
$83K
788 services
Medicare patients, 2024
400
Average age 73
Drug cost, 2024
$755K
1,085 prescriptions
Company payments, 2025
$137
From 1 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Glen H Henbest was code 45385 (colonoscopy - lesion removal), 140 times for 140 patients. In total Glen H Henbest billed 788 services in 47 codes, and Medicare paid $83K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2024-04-22.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 45385 Colonoscopy - Lesion Removal | Facility | 140 | 140 | $197.86 | $28K |
| G0500 Moderate sedation services provided by the same physician or other qualified health care professional performing a gastrointestinal endoscopic service that sedation supports, requiring the presence of an independent trained observer to assist in the monito | Facility | 112 | 110 | $4.70 | $527 |
| 43239 Upper GI Endoscopy | Facility | 70 | 69 | $68.27 | $4,779 |
| 99222 Hospital E&M - Initial | Facility | 61 | 60 | $94.29 | $5,752 |
| 99232 Hospital E&M - Subsequent | Facility | 56 | 40 | $58.71 | $3,288 |
| 99214 Office E&M - Established | Office | 47 | 42 | $65.16 | $3,063 |
| 45380 Lower GI Endoscopy - Other | Facility | 41 | 40 | $102.30 | $4,194 |
| 43248 Upper GI Endoscopy | Facility | 29 | 28 | $116.19 | $3,369 |
| 43235 Upper GI Endoscopy | Facility | 28 | 28 | $78.45 | $2,197 |
| G0105 Colorectal cancer screening; colonoscopy on individual at high risk | Facility | 24 | 24 | $174.55 | $4,189 |
| 99213 Office E&M - Established | Office | 17 | 17 | $46.49 | $790 |
| 99204 Office E&M - New | Office | 14 | 14 | $105.68 | $1,480 |
| 45378 Lower GI Endoscopy - Other | Facility | 13 | 13 | $132.43 | $1,722 |
| 99203 Office E&M - New | Office | 11 | 11 | $55.86 | $614 |
By year: 2022 $102K for 1,125 services; 2023 $100K for 1,014 services; 2024 $83K for 788 services.
Medicare prescription drug claims, 2024
In 2024, the drug Glen H Henbest prescribed most often to Medicare patients was Gavilyte-G (Peg3350/Sod Sulf,bicarb,cl/Kcl), with 197 prescriptions and refills. In total Glen H Henbest wrote 1,085 Medicare prescriptions that cost $755K.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Gavilyte-G Peg3350/Sod Sulf,bicarb,cl/Kcl | 197 | 197 | 197 | $3,496 |
| Omeprazole Generic | 148 | 329 | 53 | $3,061 |
| Peg-3350 And Electrolytes Peg3350/Sod Sulf,bicarb,cl/Kcl | 111 | 111 | 109 | $1,892 |
| Gavilyte-C Peg3350/Sod Sulf,bicarb,cl/Kcl | 82 | 82 | 82 | $1,437 |
| Peg 3350-Electrolyte Sodium Chloride/Nahco3/Kcl/Peg | 79 | 79 | 76 | $2,219 |
| Sod Sulf-Potass Sulf-Mag Sulf Sodium, Potassium,mag Sulfates | 55 | 55 | 54 | $3,956 |
| Famotidine Generic | 49 | 105 | 16 | $721 |
| Pantoprazole Sodium Generic | 48 | 124 | 15 | $1,498 |
| Budesonide Dr Budesonide | 22 | 36 | 15 | $2,338 |
| Ursodiol Generic | 16 | 28 | Under 11 | $3,591 |
| Mesalamine Generic | 15 | 33 | Under 11 | $11K |
| Cyltezo(Cf) Pen Adalimumab-Adbm | 15 | 15 | Under 11 | $229K |
| Lactulose Generic | 15 | 15 | Under 11 | $577 |
| Xifaxan Rifaximin | 15 | 15 | Under 11 | $45K |
| Humira(Cf) Pen Adalimumab | 15 | 15 | Under 11 | $182K |
Brand drugs: 243 claims; generic drugs: 842 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Glen H Henbest $137 ($137 in general payments such as food, travel and fees) from 1 company. The largest payer was Medtronic, Inc. with $137.
| Company | Payments | Amount |
|---|---|---|
| Medtronic, Inc. MDT | 2 | $137 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.